Business Description
![Kuros Biosciences Ltd Kuros Biosciences Ltd logo](https://static.gurufocus.com/logos/0C00000WYP.png?14)
Kuros Biosciences Ltd
ISIN : CH0325814116
Compare
Compare
Traded in other countries / regions
KURN.Switzerland0RHR.UKCSBTF.USAYTSN.Germany IPO Date
2002-10-29Description
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.47 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 16.89 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 76.8 | |||||
3-Year EBITDA Growth Rate | 6.9 | |||||
3-Year EPS without NRI Growth Rate | 6.8 | |||||
3-Year FCF Growth Rate | 13.6 | |||||
3-Year Book Growth Rate | -15.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.43 | |||||
9-Day RSI | 55.02 | |||||
14-Day RSI | 58.75 | |||||
6-1 Month Momentum % | 106.52 | |||||
12-1 Month Momentum % | 558.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.06 | |||||
Quick Ratio | 1.69 | |||||
Cash Ratio | 1.05 | |||||
Days Inventory | 156.89 | |||||
Days Sales Outstanding | 48.54 | |||||
Days Payable | 47.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -0.13 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.32 | |||||
Operating Margin % | -39.3 | |||||
Net Margin % | -40.9 | |||||
FCF Margin % | -27.32 | |||||
ROE % | -21.73 | |||||
ROA % | -17.7 | |||||
ROIC % | -22.47 | |||||
ROC (Joel Greenblatt) % | -482.8 | |||||
ROCE % | -20.26 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 12.83 | |||||
PB Ratio | 7.61 | |||||
Price-to-Tangible-Book | 27.43 | |||||
EV-to-EBIT | -32.03 | |||||
EV-to-EBITDA | -40.5 | |||||
EV-to-Revenue | 12.56 | |||||
EV-to-FCF | -45.97 | |||||
Price-to-Median-PS-Value | 0.98 | |||||
Price-to-Net-Current-Asset-Value | 34.51 | |||||
Earnings Yield (Greenblatt) % | -3.12 | |||||
FCF Yield % | -2.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kuros Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 33.564 | ||
EPS (TTM) (CHF) | -0.38 | ||
Beta | 1.31 | ||
Volatility % | 92.17 | ||
14-Day RSI | 58.75 | ||
14-Day ATR (CHF) | 0.681829 | ||
20-Day SMA (CHF) | 11.733 | ||
12-1 Month Momentum % | 558.78 | ||
52-Week Range (CHF) | 1.36 - 12.96 | ||
Shares Outstanding (Mil) | 36.91 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kuros Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kuros Biosciences Ltd Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Kuros Biosciences Ltd Frequently Asked Questions
What is Kuros Biosciences Ltd(XSWX:KURN)'s stock price today?
The current price of XSWX:KURN is CHF11.74. The 52 week high of XSWX:KURN is CHF12.96 and 52 week low is CHF1.36.
When is next earnings date of Kuros Biosciences Ltd(XSWX:KURN)?
The next earnings date of Kuros Biosciences Ltd(XSWX:KURN) is .
Does Kuros Biosciences Ltd(XSWX:KURN) pay dividends? If so, how much?
Kuros Biosciences Ltd(XSWX:KURN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |